"I am pleased to announce the appointments of such an esteemed trio of Alzheimer's researchers to Amarantus Diagnostics' inaugural Scientific Advisory Board," said Gerald E. Commissiong, President & CEO of Amarantus.

I believe that was AMBSDX's 3rd big move!

Amarantus Diagnostics
1) cornered the ALZ. market.
2) has a MSDX near ready for the Commercial market
3) assembled a DREAMTEAM of a SAB (to start with)

And January isn't even over yet!!!

Hahahha Cheers